60 Degrees Pharms Drug Patent Portfolio
60 Degrees Pharms owns 1 orange book drug protected by 3 US patents Given below is the list of 60 Degrees Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10342791 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | 02 Dec, 2035 | Active |
| US10888558 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | 02 Dec, 2035 | Active |
| US11744828 | Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects | 02 Dec, 2035 | Active |
Latest Legal Activities on 60 Degrees Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of 60 Degrees Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 26 Jun, 2024 | US10888558 |
|
Email Notification
Critical
| 05 Sep, 2023 | US11744828 |
| Mail Patent eGrant Notification | 05 Sep, 2023 | US11744828 |
| Patent eGrant Notification | 05 Sep, 2023 | US11744828 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Sep, 2023 | US11744828 |
| Recordation of Patent eGrant | 05 Sep, 2023 | US11744828 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Sep, 2023 | US11744828 |
|
Electronic Review
Critical
| 17 Aug, 2023 | US11744828 |
|
Email Notification
Critical
| 17 Aug, 2023 | US11744828 |
|
Issue Notification Mailed
Critical
| 16 Aug, 2023 | US11744828 |
|
Application Is Considered Ready for Issue
Critical
| 26 Jul, 2023 | US11744828 |
| Dispatch to FDC | 26 Jul, 2023 | US11744828 |
|
Issue Fee Payment Received
Critical
| 17 Jul, 2023 | US11744828 |
|
Issue Fee Payment Verified
Critical
| 17 Jul, 2023 | US11744828 |
| Miscellaneous Incoming Letter | 11 Jul, 2023 | US11744828 |
60 Degrees Pharms's Family Patents
60 Degrees Pharms drugs have patent protection in a total of 7 countries. It's US patent count contributes only to 46.2% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
60 Degrees Pharms Drug List
Given below is the complete list of 60 Degrees Pharms's drugs and the patents protecting them.
1. Arakoda
Arakoda is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10342791 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects |
02 Dec, 2035
(11 years from now)
| Active |
| US10888558 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects |
02 Dec, 2035
(11 years from now)
| Active |
| US11744828 | Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects |
02 Dec, 2035
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arakoda's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List